Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2010 | 2 |
2011 | 1 |
2012 | 2 |
2014 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate cancer.
Oncol Rep. 2012 Jan;27(1):3-9. doi: 10.3892/or.2011.1487. Epub 2011 Oct 4.
Oncol Rep. 2012.
PMID: 21971890
Clinical Trial.
Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate.
Kim W, Jones JO, Diamond M, Haqq C, Molina A, Small EJ, Ryan CJ.
Kim W, et al.
Prostate Cancer Prostatic Dis. 2014 Sep;17(3):292-9. doi: 10.1038/pcan.2014.27. Epub 2014 Jul 22.
Prostate Cancer Prostatic Dis. 2014.
PMID: 25047002
Item in Clipboard
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.
Ryan CJ, Smith MR, Fong L, Rosenberg JE, Kantoff P, Raynaud F, Martins V, Lee G, Kheoh T, Kim J, Molina A, Small EJ.
Ryan CJ, et al.
J Clin Oncol. 2010 Mar 20;28(9):1481-8. doi: 10.1200/JCO.2009.24.1281. Epub 2010 Feb 16.
J Clin Oncol. 2010.
PMID: 20159824
Free PMC article.
Clinical Trial.
Item in Clipboard
Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II study.
Friedlander TW, Weinberg VK, Small EJ, Sharib J, Harzstark AL, Lin AM, Fong L, Ryan CJ.
Friedlander TW, et al.
Urol Oncol. 2012 Jul-Aug;30(4):408-14. doi: 10.1016/j.urolonc.2010.06.014. Epub 2010 Oct 2.
Urol Oncol. 2012.
PMID: 20884247
Clinical Trial.
Item in Clipboard
Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.
Ryan CJ, Zavodovskaya M, Youngren JF, Campbell M, Diamond M, Jones J, Shiry L, Allan G, Maddux BA, Goldfine ID.
Ryan CJ, et al.
Prostate. 2008 Aug 1;68(11):1232-40. doi: 10.1002/pros.20789.
Prostate. 2008.
PMID: 18491370
Free PMC article.
Item in Clipboard
Cite
Cite